MedTrace Logo

Person-Centered Psychosis Care: An Educational Intervention

NCT03182283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-11-08

No results posted yet for this study

Summary

Schizophrenia is a major mental illness that presents in young adulthood and affects \~1% of the population. Impact on affected persons life is often major and life expectancy is reduced by \~20 years. Better and more effective care models are needed to increase health in these persons. Person-centered care have been suggested to be one way to increase efficiency in care delivery for patients with chronical and complex conditions. The impact of person-centered care on a inpatient psychosis care setting is now being tested.

The purpose of this study is to test whether inpatient Person-centered psychosis care (PCPC) can

1. increase patient empowerment
2. improve patient satisfaction
3. reduce the frequency of involuntary treatments
4. reduce the duration of inpatient care and
5. reduce overall ward burden

A further purpose is to qualitatively explore which components in this complex intervention are experienced as facilitators or barriers to the achievement of good care, from both patient, next-of-kin and staff perspectives.

Quantitative data is collected through questionnaires from patients (measuring empowerment, care satisfaction and perceived health) before and after an educational intervention for staff, along with ward level measures such as care burden, number of involuntary treatments and length of stay on ward.

Qualitative interview is used to study experiences of patients, next-of-kin and staff.

Conditions

  • Patient-Centered Care
  • Psychiatry
  • Inpatient
  • Psychosis

Interventions

BEHAVIORAL

Person-centered psychosis care

Person-centered care educational intervention for staff with following implementation of person-centered care in the clinic

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Swedish Council for Working Life and Social Research

    collaborator OTHER

  • Göteborg University

    lead OTHER

Principal Investigators

  • Margda Waern, Professor · Göteborg University & Sahlgrenska University Hospital

  • Anneli Goulding, Phd · Sahlgrenska University Hospital & Göteborg University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-25
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182283 on ClinicalTrials.gov